Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
job cuts
Biotech
TScan lays off 30% of workforce, halts solid tumor TCR trial
TScan is laying off 30% of its workforce as the T-cell receptor therapy biotech focuses on patients with blood cancers.
James Waldron
Nov 3, 2025 8:25am
Genentech lets 118 staffers go in another HQ layoff round
Oct 29, 2025 4:55pm
Kezar plans layoffs after FDA axes meeting to discuss next trial
Oct 17, 2025 8:55am
Big pharma cuts and gene therapy woes: Inside Q3's layoffs
Oct 3, 2025 4:30pm
Bolt halves workforce again to find cash for cancer drug readout
Oct 2, 2025 6:45am
Sutro loses 3rd of workforce in 2nd round of layoffs this year
Sep 30, 2025 4:16am